Preventing HIV, STIs Through School-Based Programs

Although a positive impact on behavior change has been reported following the implementation of curriculum-based programs, there is a lack of clear evidence that school-based ...

HPV Infection in HIV Increases Cervical Cancer Risk

Women with HIV have an increased risk for persistent HPV infection, which frequently progresses to cervical cancer, and they should be warned of their increased ...

Pausing ART: Safety and Ethical Considerations

Dr Gianella Weibel talks with Dr Li and Dr Dubé, investigators of a new study from the AIDS Clinical Trials Group, which uses an intensively ...

Microbiome and HIV

The interactions between HIV, ART, human sexual behavior, and the gut microbiome are complex and sorting out these interactions will be important to design future ...

Increasing HIV Viral Suppression Rates Through Financial Incentives

Use of incentives makes the most sense with disadvantaged populations including homeless, drug users, and people in developing countries.

PrEP for Adolescents at Risk for HIV

Experts discuss new findings supporting the need for PrEP in adolescents and discuss the continued debate surrounding parental consent and other relevant issues.

Risk Factors of Neurocognitive Decline in HIV+ Individuals

The incidence of neurocognitive impairment is high in HIV-infected population, despite the introduction of combination antiretroviral therapy (CART).

Understanding Why Patients Discontinue ART and Increasing Adherence

Learn more about when stopping antiretroviral therapy (ART) may be necessary, why patients discontinue ART, predicting viral suppression, and predicting and encouraging adherence.
HIV/AIDS

Latest News

One-Time Routine HIV Screening at Age 25 Optimal With No Risk Factors

One-Time Routine HIV Screening at Age 25 Optimal With No Risk Factors

Using adult quality-of-life weights for adolescents and young adults increased the incremental cost-effectiveness ratios of screen at 25 compared to screen at age 30 to $115,900/quality-adjusted life-year.

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Transcutaneous vagus nerve stimulation could provide a safe alternative treatment in HIV-depression by targeting both depression and other comorbidities that can burden people living with HIV.

Psychosocial Risk Factors in Adolescence Linked to HIV Vulnerability in Adulthood

Psychosocial Risk Factors in Adolescence Linked to HIV Vulnerability in Adulthood

High-frequency psychosocial risk factors during adolescence have a lasting effect on the likelihood of engaging in HIV risk behaviors in adulthood.

Primary Care: Next Frontier in Managing HIV Care

Primary Care: Next Frontier in Managing HIV Care

Primary care providers will play an important role in preventing the next wave of HIV infections.

Hepatitis B Vaccination Prevalence Low in Patients With HIV

Hepatitis B Vaccination Prevalence Low in Patients With HIV

More than one-third of adult US HIV patients miss opportunities to initiate hepatitis B vaccination.

Value of Confirmatory Testing of Early Infant Diagnosis for HIV

Value of Confirmatory Testing of Early Infant Diagnosis for HIV

Confirmatory testing is valuable and cost-effective for assessing HIV in infants considering false-positive rates of more than 10% when using nucleic acid amplification testing.

More Evidence That Early Diagnosis of HIV and Early ART Are Beneficial

More Evidence That Early Diagnosis of HIV and Early ART Are Beneficial

Since early ART limits HIV reservoir size and preserves central memory CD4 cells, patients treated from primary HIV infection with low HIV-DNA levels might be good candidates for future HIV cure strategies.

Low Adherence to Guidelines for Cardiovascular Care in HIV

Low Adherence to Guidelines for Cardiovascular Care in HIV

A new study sought to qualify the adherence to evidence-based cardiovascular care guidelines for patients living with HIV.

Treatment Regimens and Recommendations for HIV/HCV Coinfection

Treatment Regimens and Recommendations for HIV/HCV Coinfection

Experts discuss the management of drug-drug interactions in patients receiving treatment for HIV and HCV coinfection.

Breastfeeding Mediates Pneumonia Outcomes in HIV-Exposed Children

Breastfeeding Mediates Pneumonia Outcomes in HIV-Exposed Children

Investigators evaluated pneumonia outcomes and HIV exposure with birth weight status, malnutrition, breast feeding, in utero exposure to combination antiretroviral therapy, or the severity of pneumonia.

Feature Article

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Transcutaneous vagus nerve stimulation could provide a safe alternative treatment in HIV-depression by targeting both depression and other comorbidities that can burden people living with HIV.

Bone Loss and Fracture Risk in Patients With HIV: What We Know So Far

Bone Loss and Fracture Risk in Patients With HIV: What We Know So Far

In addition to prevention measures, switching off the ARTs associated with bone loss and administering intravenous bisphosphonate, a bone resorption inhibitor, can be an effective strategy for preventing bone loss seen in HIV-infected individuals.

Aging With HIV: Expert Insights on Complications and Challenges

Aging With HIV: Expert Insights on Complications and Challenges

Three HIV experts provide their insights into aging-related challenges and complications faced by people living with HIV.

ART and PrEP: How Technological Advances Can Improve Adherence

ART and PrEP: How Technological Advances Can Improve Adherence

Several technological advances have been developed to improve adherence to antiretroviral and preexposure prophylaxis therapy.

Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Anthony B, a patient with HIV and end-stage amyotrophic lateral sclerosis and the first participant enrolled in the "Last Gift" end-of-life study, about his experience as part of this new end-of-life model to study HIV persistence.

Last Gift Study: Community Perspective on End-of-Life HIV Research

Last Gift Study: Community Perspective on End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Jeff Taylor, community activist and long-term HIV survivor, about a new end-of-life model to study HIV persistence.

Last Gift Study: End-of-Life HIV Research

Last Gift Study: End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Dr Davey Smith, head of the Division of Infectious Disease at the University of California, San Diego, about a proposed new model to study HIV persistence, called the Last Gift study.

A Transgender Woman's Perspective on HIV Research, Prevention, and Care

A Transgender Woman's Perspective on HIV Research, Prevention, and Care

Dr Sara Gianella talks with Brooke Sullivan, a transgender woman and HIV activist, about ways to improve transgender individuals' involvement in HIV research.

PrEP in the Transgender Population: New Study to Examine Effects

PrEP in the Transgender Population: New Study to Examine Effects

Dr Sara Gianella talks with Dr Sheldon Morris, from the University of California San Diego AntiViral Research Center about an upcoming PrEP study in transgender people, including understanding HIV prevention in this population, uptake of PrEP, and adherence to treatment.

HIV Transmission Through Breastfeeding: New Review and Expert Interview

HIV Transmission Through Breastfeeding: New Review and Expert Interview

Mother-to-child HIV transmission rates are low in the presence of antiretroviral therapy but increase once ART stops at 6 months postpartum.

Slideshows

SIGN UP FOR FREE E-NEWSLETTERS